Joseph M. Burnett's most recent trade in ClearPoint Neuro Inc was a trade of 20,000 Common Stock done at an average price of $2.5 . Disclosure was reported to the exchange on Jan. 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.50 per share. | 09 Jan 2026 | 20,000 | 31,565 (0%) | 0% | 2.5 | 50,000 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 16.12 per share. | 09 Jan 2026 | 20,000 | 11,565 (0%) | 0% | 16.1 | 322,400 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2026 | 20,000 | 330,000 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 9.57 per share. | 31 Dec 2025 | 254 | 11,565 (0%) | 0% | 9.6 | 2,431 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 26.51 per share. | 10 Oct 2025 | 17,583 | 225,939 (1%) | 0% | 26.5 | 466,125 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 27.64 per share. | 10 Oct 2025 | 6,599 | 219,340 (1%) | 0% | 27.6 | 182,396 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 28.64 per share. | 10 Oct 2025 | 1,981 | 217,359 (1%) | 0% | 28.6 | 56,736 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 29.21 per share. | 10 Oct 2025 | 300 | 217,059 (1%) | 0% | 29.2 | 8,763 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 10.15 per share. | 30 Jun 2025 | 1,424 | 11,311 (0%) | 0% | 10.2 | 14,454 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.29 per share. | 10 Jun 2025 | 15,476 | 9,887 (0%) | 0% | 13.3 | 205,676 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 13.29 per share. | 09 Jun 2025 | 21,247 | 243,522 (1%) | 0% | 13.3 | 282,373 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 42,414 | 313,537 (2%) | 0% | - | Common Stock | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 42,414 | 169,657 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.18 per share. | 12 Mar 2025 | 23,405 | 290,132 (1%) | 0% | 13.2 | 308,478 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 47,407 | 297,283 (1%) | 0% | - | Common Stock | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 47,407 | 47,407 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.19 per share. | 06 Mar 2025 | 26,160 | 271,123 (1%) | 0% | 13.2 | 345,050 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 132,841 | 132,841 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 4.53 per share. | 31 Dec 2024 | 251 | 249,876 (1%) | 0% | 4.5 | 1,137 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.26 per share. | 20 Aug 2024 | 3,236 | 249,625 (1%) | 0% | 11.3 | 36,437 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 4.58 per share. | 28 Jun 2024 | 3,500 | 252,861 (1%) | 0% | 4.6 | 16,030 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.74 per share. | 10 Jun 2024 | 14,003 | 249,361 (1%) | 0% | 5.7 | 80,377 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 212,071 | 212,071 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 23,704 | 94,814 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 23,704 | 274,430 (1%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.24 per share. | 06 Mar 2024 | 11,066 | 263,364 (1%) | 0% | 6.2 | 69,052 | Common Stock |
| ClearPoint Neuro Inc | Joseph Burnett M. | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 5.77 per share. | 29 Dec 2023 | 1,067 | 250,726 (1%) | 0% | 5.8 | 6,157 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.58 per share. | 09 Jul 2023 | 6,122 | 249,659 (1%) | 0% | 6.6 | 40,283 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 6.15 per share. | 30 Jun 2023 | 2,095 | 255,781 (1%) | 0% | 6.1 | 12,884 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.91 per share. | 10 Jun 2023 | 6,952 | 253,686 (1%) | 0% | 6.9 | 48,038 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 118,518 | 118,518 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 39,506 | 39,506 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.24 per share. | 20 Aug 2022 | 1,457 | 260,638 (1%) | 0% | 13.2 | 19,291 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 16.07 per share. | 15 Aug 2022 | 18,867 | 262,095 (1%) | 0% | 16.1 | 303,193 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.02 per share. | 15 Aug 2022 | 7,778 | 280,962 (1%) | 0% | 16.0 | 124,604 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.24 per share. | 09 Jul 2022 | 6,664 | 286,585 (1%) | 0% | 14.2 | 94,895 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 70,113 | 293,249 (1%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 46,742 | 46,742 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 17.98 per share. | 21 Sep 2021 | 9,637 | 231,787 (1%) | 0% | 18.0 | 173,273 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 29,377 | 29,377 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 14,688 | 241,424 (1%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.70 per share. | 15 Aug 2021 | 7,353 | 226,736 (1%) | 0% | 17.7 | 130,148 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.54 per share. | 09 Jul 2021 | 3,277 | 234,089 (1%) | 0% | 18.5 | 60,756 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 18.57 per share. | 21 Jun 2021 | 25,000 | 237,366 (1%) | 0% | 18.6 | 464,250 | Common Stock |